cdifffoundation.org
Recurrent C. difficile Infection – Treatment; Rebiotix, Inc. Initiates Second Clinical Trial (PUNCH CD 2)
Rebiotix Inc. is a results-oriented biotechnology company revolutionizing the treatment of challenging gastrointestinal diseases by harnessing the power of the human microbiome. The company has com…